EmPAC (reformulated paclitaxel) / Cornerstone Pharma 
Welcome,         Profile    Billing    Logout  
 0 Diseases   0 Trials   0 Trials   10 News 
  • ||||||||||  EmPAC (reformulated paclitaxel) / Cornerstone Pharma
    Trial completion date, Trial primary completion date:  EMPAC-BDD: TMS Visual Modulation in Body Dysmorphic Disorder (clinicaltrials.gov) -  Feb 24, 2025   
    P=N/A,  N=40, Recruiting, 
    Trial completion date: Oct 2024 --> Oct 2025 | Trial primary completion date: Jul 2024 --> Jul 2025
  • ||||||||||  EmPAC (reformulated paclitaxel) / Cornerstone Pharma
    Enrollment open:  EMPAC-BDD: TMS Visual Modulation in Body Dysmorphic Disorder (clinicaltrials.gov) -  May 23, 2023   
    P=N/A,  N=40, Recruiting, 
    Trial completion date: Oct 2024 --> Oct 2025 | Trial primary completion date: Jul 2024 --> Jul 2025 Not yet recruiting --> Recruiting
  • ||||||||||  EmPAC (reformulated paclitaxel) / Cornerstone Pharma
    Trial initiation date:  EMPAC-BDD: TMS Visual Modulation in Body Dysmorphic Disorder (clinicaltrials.gov) -  Feb 8, 2023   
    P=N/A,  N=40, Not yet recruiting, 
    Not yet recruiting --> Recruiting Initiation date: Dec 2022 --> Mar 2023